PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to <18 Years of Age with ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...

Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company with a market capitalization of $183 million, announced today that their partner, Norgine Pharmaceuticals Ltd., has launched PEDMARQSI ...

Up until now, old school characters from the original Star Wars trilogy had been banned from Black Spire Outpost by Walt ...

If you’re curious as to how and why cows, nuclear reactors, tricycles, peperami, and old people doing yoga all fit into one ...

There will be plenty of new "Star Wars" content for fans to feast on over the next few years -- here are all the projects ...

Disneyland is set to introduce two major additions during Season of the Force in 2025: a new nighttime projection show in ...